DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Graff J, Harder S.
Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment.
Clin Pharmacokinet 2013;
52 (04) 243-254
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.